Healio: Minimally Symptomatic Patients Likely to Survive with Good Health Status After TAVR

Patients with minimally symptomatic status who underwent transcatheter aortic valve replacement (TAVR) were more likely to survive with good health status at one year than more symptomatic patients, researchers reported.

"There is growing interest in earlier timing of TAVR," said Dr. Chetan Huded, an intervential cardiologist and medical director of the left atrial appendage closure program at Saint Luke's Mid America Heart Institute, and colleagues. "A key insight needed to better understand the risks and benefits of this approach is a deeper understanding of the outcomes of TAVR in asymptomatic or minimally symptomatic patients with severe aortic stenosis."

Read the full Healio article: Minimally Symptomatic Patients Likely to Survive with Good Health Status After TAVR 

Related Content

Sep. 12, 2023

TCTMD: Nonwhite Cardiac Arrest Victims Are More Likely to Die Prehospital: Why?
TCTMD talked to Dr. Paul Chan and Dr. Anezi Uzendu about the new study's findings.
Sep. 7, 2023

KSHB: Kansas City Doctors Are at Center of Breakthrough Research for Heart Failure Patients
KSHB talked to Dr. Mikhail Kosiborod, a cardiologist at Saint Luke’s Mid America Heart Institute and the study’s lead investigator, and Nancy Collins, a patient who was enrolled in the study.
Aug. 28, 2023

New York Times: Obesity Treatment Relieves Heart Failure Symptoms, Drugmaker’s Study Finds
The drug Wegovy eased issues for people with a type of heart problem, adding to the treatment’s benefits beyond weight loss.